Trials / Completed
CompletedNCT01740895
ADenosine Vasodilator Independent Stenosis Evaluation II - ADVISE II
A Prospective, Observational, Non-randomized, Double Blind, Global, Multi-center Registry With an Adaptive Design, Investigating the Diagnostic Utility of Instantaneous Wave-free Ratio™ (iFR®) in Assessing Coronary Stenosis Relevance.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 818 (actual)
- Sponsor
- Volcano Corporation · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To assess the clinical value of iFR to characterize, without concomitant administration of hyperemic agents and outside a specified range of iFR values, coronary stenosis severity as determined with fractional flow reserve (FFR)
Conditions
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-12-04
- Last updated
- 2014-08-06
Locations
44 sites across 8 countries: United States, Canada, Egypt, Germany, Netherlands, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01740895. Inclusion in this directory is not an endorsement.